Paroxetine in the treatment of anxiety disorders

Czech version

Authors: R. Honzák ^1,2; B. Seifert ²
Authors‘ workplace: Psychiatrická katedra IPVZ, Praha, vedoucí prof. MUDr. K. Chromý, CSc. 2Ústav všeobecného lékařství 1. LF UK, Praha, přednosta MUDr. B. Seifert ¹
Published in: Prakt. Lék. 2004; (6): 313-316
Category:

Overview

This article provides an overview of the use of paroxetine in the treatment of anxiety disordersin patients of the general practitioner. The efficacy and safety of paroxetine have been studiedin several anxiety disorders. The epidemiology, diagnosis, and course of agoraphobia, generalizedanxiety disorder, specific phobia, obsessive-compulsive disorder, social anxiety disorder,panic disorder, and posttraumatic stress disorder are discussed briefly. Current available dataon the safety and efficacy of paroxetine based on double-blind, placebo-controlled trials andopen-label studies for the treatment of anxiety disorders are reviewed. Clinical guidelines forthe use of paroxetine and recommendations regarding future directions of study are discussed.

Key words:
anxiety disorders - diagnosis - treatment - paroxetine.

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

General practitioner for children and adolescents General practitioner for adults

Vaccination against influenza as a means of preventing sudden cardiovascular andcerebrovascular events in high-risk population groups

Bovine tuberculosis in free-living animals andthe hazard of human infection

Treatment of atrial fibrilation - a clear objectivewith a still obscure resolution

Cognitive-behavioral therapy in obesity (Attaining and sustaining changes in eatinghabits and physical excercise, and weight losses)

A fettered life... by/with dialysis?

Article was published in

General Practitioner

2004 Issue 6